Prothena Corp PLC (PRTA)
20.57
-0.43
(-2.05%)
USD |
NASDAQ |
Apr 18, 16:00
20.60
+0.03
(+0.15%)
Pre-Market: 20:00
Prothena Net Income (Quarterly): -67.48M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -67.48M |
| September 30, 2023 | 21.91M |
| June 30, 2023 | -54.60M |
| March 31, 2023 | -46.86M |
| December 31, 2022 | 6.349M |
| September 30, 2022 | -45.76M |
| June 30, 2022 | -41.24M |
| March 31, 2022 | -36.29M |
| December 31, 2021 | -33.18M |
| September 30, 2021 | 109.25M |
| June 30, 2021 | 27.64M |
| March 31, 2021 | -36.74M |
| December 31, 2020 | -30.72M |
| September 30, 2020 | -30.58M |
| June 30, 2020 | -26.28M |
| March 31, 2020 | -23.57M |
| December 31, 2019 | -21.55M |
| September 30, 2019 | -19.45M |
| June 30, 2019 | -15.81M |
| March 31, 2019 | -20.86M |
| December 31, 2018 | -22.46M |
| September 30, 2018 | -24.56M |
| June 30, 2018 | -59.88M |
| March 31, 2018 | -48.74M |
| Date | Value |
|---|---|
| December 31, 2017 | -47.76M |
| September 30, 2017 | -52.39M |
| June 30, 2017 | -17.70M |
| March 31, 2017 | -35.38M |
| December 31, 2016 | -48.90M |
| September 30, 2016 | -43.24M |
| June 30, 2016 | -40.44M |
| March 31, 2016 | -27.52M |
| December 31, 2015 | -24.16M |
| September 30, 2015 | -22.98M |
| June 30, 2015 | -18.28M |
| March 31, 2015 | -15.20M |
| December 31, 2014 | -13.11M |
| September 30, 2014 | -13.18M |
| June 30, 2014 | 1.29M |
| March 31, 2014 | 17.85M |
| December 31, 2013 | -11.05M |
| September 30, 2013 | -9.689M |
| June 30, 2013 | -11.30M |
| March 31, 2013 | -8.951M |
| December 31, 2012 | -12.22M |
| September 30, 2012 | -8.668M |
| June 30, 2012 | -9.711M |
| March 31, 2012 | -10.81M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-67.48M
Minimum
Dec 2023
109.25M
Maximum
Sep 2021
-19.21M
Average
-30.58M
Median
Sep 2020
Net Income (Quarterly) Benchmarks
| Amarin Corp PLC | -5.781M |
| Jazz Pharmaceuticals PLC | 94.15M |
| Iterum Therapeutics PLC | -12.36M |
| GH Research PLC | -11.27M |
| Mural Oncology PLC | -59.54M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.316M |
| Total Expenses (Quarterly) | 78.83M |
| EPS Diluted (Quarterly) | -1.26 |
| Enterprise Value | 486.20M |
| Profit Margin (Quarterly) | -21.35K% |
| Earnings Yield | -13.61% |
| Normalized Earnings Yield | -13.61 |